NL-OMON54658招募中不适用
Circulating tumor DNA based adjuvant chemotherapy in stage II colon cancer patients: the MEDOCC-CrEATE trial - MEDOCC-CrEATE
niversitair Medisch Centrum Utrecht0 个研究点目标入组 1,320 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age >= 18 years
- •- Informed consent for PLCRC with specific consent for additional blood
- •withdrawals, collection of tissue and being informed about future experimental
- •- Histological confirmed stage II colon cancer
- •- Fit for combination chemotherapy (fluoropyrimidin and oxaliplatin) according
- •to the treating physician
排除标准
- •- Indication for adjuvant chemotherapy according to treating physician
- •- Another malignancy in previous 5 years, except carcinoma in situ or skin
- •cancer other than melanoma
- •- Incomplete tumor resection (R1 or R2 resection)
- •- Contra-indications for fluoropyrimidines or oxaliplatin
- •- Pregnancy
研究者
相似试验
进行中（未招募）
1 期
Circulating tumour DNA based decision for adjuvant treatment in colon cancer stage II evaluation (CIRCULATE) AIO-KRK-0217Colon cancer stage IIMedDRA version: 21.0Level: PTClassification code 10009954Term: Colon cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10038049Term: Rectal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-003691-12-DETechnische Universität Dresden4,812
招募中
3 期
Circulating tumour DNA based decision for adjuvant treatment in colon cancer stage II evaluation (CIRCULATE), AIO-KRK-0217DRKS00018695Technische Universität Dresden4,812
招募中
1 期
CIRCULATEcolon cancer stage II, rectal cancer stage IIMedDRA version: 21.0Level: PTClassification code: 10009954Term: Colon cancer stage II Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10038049Term: Rectal cancer stage II Class: 100000004864CTIS2023-506715-18-00Technische Universitat Dresden140
终止
不适用
se of circulating tumour DNA (ctDNA) results to inform the decision for adjuvant chemotherapy in patients with locally advanced rectal cancer who have been treated with pre-operative chemo-radiation and surgery.ACTRN12617001560381AGITG250
终止
2 期
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Early Stage Pancreatic Cancer: A Multicentre Randomised Study (DYNAMIC- Pancreas)Cancer - PancreaticPancreatic CancerACTRN12618000335291Australasian Gastro-Intestinal Trials Group118